Unilever still keen on health unit after bid rebuffed

Unilever still keen on health unit after bid rebuffed

The consumer goods giant says its future lies in materially expanding its presence.

LONDON:
Consumer goods giant Unilever today revealed ongoing interest in a consumer healthcare unit jointly owned with pharmaceutical groups GlaxoSmithKline and Pfizer after a bid of £50 billion was refused.

“GSK Consumer Healthcare would be a strong strategic fit,” Unilever said in a statement as it unveiled a strategy update in the wake of the weekend’s takeover news.

Unilever said it was “committed to accelerating the company’s growth and repositioning the portfolio into higher growth categories”.

GSK said on Saturday that it had received three unsolicited offers from Unilever for GSK Consumer Healthcare, but they were all rejected as the company said the unit was undervalued.

“As a result of the reporting of Unilever’s interest in GSK Consumer Healthcare, we are today bringing forward a planned update, setting out the strategic direction that the company is pursuing,” Unilever said.

Unilever said its “future strategic direction lies in materially expanding its presence in health, beauty and hygiene”.

Stay current - Follow FMT on WhatsApp, Google news and Telegram

Subscribe to our newsletter and get news delivered to your mailbox.